ALNXT Fundamental Analysis - NEXTEDIA

Fundamental Rating

Taking everything into account, ALNXT scores 5 out of 10 in our fundamental rating. ALNXT was compared to 76 industry peers in the IT Services industry. While ALNXT seems to be doing ok healthwise, there are quite some concerns on its profitability. ALNXT is valued quite cheap, while showing a decent growth score. This is a good combination!

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALNXT was profitable.
In the past year ALNXT had a positive cash flow from operations.
Each year in the past 5 years ALNXT has been profitable.
ALNXT had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 2.83%, ALNXT is doing worse than 60.53% of the companies in the same industry.
With a Return On Equity value of 4.93%, ALNXT is not doing good in the industry: 63.16% of the companies in the same industry are doing better.
ALNXT has a Return On Invested Capital (6.30%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for ALNXT is significantly below the industry average of 25.87%.
The last Return On Invested Capital (6.30%) for ALNXT is above the 3 year average (6.20%), which is a sign of increasing profitability.

		Industry Rank	Sector Rank
ROA	2.83%
ROE	4.93%
ROIC	6.3%

ROA(3y)2.64%

ROA(5y)3.08%

ROE(3y)5.31%

ROE(5y)6.42%

ROIC(3y)6.2%

ROIC(5y)6.1%

1.3 Margins

Looking at the Profit Margin, with a value of 2.50%, ALNXT is in line with its industry, outperforming 43.42% of the companies in the same industry.
ALNXT's Profit Margin has declined in the last couple of years.
ALNXT's Operating Margin of 5.15% is in line compared to the rest of the industry. ALNXT outperforms 47.37% of its industry peers.
ALNXT's Operating Margin has declined in the last couple of years.
ALNXT has a worse Gross Margin (54.19%) than 60.53% of its industry peers.
ALNXT's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	5.15%
PM (TTM)	2.5%
GM	54.19%

OM growth 3Y-10.16%

OM growth 5Y-2.26%

PM growth 3Y-8.02%

PM growth 5Y-2.63%

GM growth 3Y-8.46%

GM growth 5Y-11.02%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALNXT is destroying value.
Compared to 1 year ago, ALNXT has about the same amount of shares outstanding.
The number of shares outstanding for ALNXT has been increased compared to 5 years ago.
The debt/assets ratio for ALNXT has been reduced compared to a year ago.

2.2 Solvency

ALNXT has an Altman-Z score of 2.15. This is not the best score and indicates that ALNXT is in the grey zone with still only limited risk for bankruptcy at the moment.
ALNXT's Altman-Z score of 2.15 is on the low side compared to the rest of the industry. ALNXT is outperformed by 60.53% of its industry peers.
ALNXT has a debt to FCF ratio of 3.10. This is a good value and a sign of high solvency as ALNXT would need 3.10 years to pay back of all of its debts.
With a Debt to FCF ratio value of 3.10, ALNXT perfoms like the industry average, outperforming 56.58% of the companies in the same industry.
A Debt/Equity ratio of 0.12 indicates that ALNXT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.12, ALNXT belongs to the top of the industry, outperforming 80.26% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.12
Debt/FCF	3.1
Altman-Z	2.15

ROIC/WACC0.92

WACC6.83%

2.3 Liquidity

A Current Ratio of 1.25 indicates that ALNXT should not have too much problems paying its short term obligations.
ALNXT has a Current ratio (1.25) which is in line with its industry peers.
A Quick Ratio of 1.25 indicates that ALNXT should not have too much problems paying its short term obligations.
ALNXT's Quick ratio of 1.25 is in line compared to the rest of the industry. ALNXT outperforms 59.21% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.25
Quick Ratio	1.25

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 48.13% over the past year.
Measured over the past 5 years, ALNXT shows a small growth in Earnings Per Share. The EPS has been growing by 3.66% on average per year.
Looking at the last year, ALNXT shows a decrease in Revenue. The Revenue has decreased by -2.25% in the last year.
Measured over the past years, ALNXT shows a very strong growth in Revenue. The Revenue has been growing by 21.48% on average per year.

EPS 1Y (TTM)48.13%

EPS 3Y-3.66%

EPS 5Y3.66%

EPS Q2Q%4.76%

Revenue 1Y (TTM)-2.25%

Revenue growth 3Y8.74%

Revenue growth 5Y21.48%

Sales Q2Q%-8.17%

3.2 Future

Based on estimates for the next years, ALNXT will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.47% on average per year.
ALNXT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.18% yearly.

EPS Next Y20.64%

EPS Next 2Y9.47%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year13.87%

Revenue Next 2Y8.18%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALNXT is valuated reasonably with a Price/Earnings ratio of 10.70.
Based on the Price/Earnings ratio, ALNXT is valued cheaper than 93.42% of the companies in the same industry.
ALNXT is valuated cheaply when we compare the Price/Earnings ratio to 27.33, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 4.62 indicates a rather cheap valuation of ALNXT.
Based on the Price/Forward Earnings ratio, ALNXT is valued cheaper than 94.74% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ALNXT to the average of the S&P500 Index (24.12), we can say ALNXT is valued rather cheaply.

		Industry Rank	Sector Rank
PE	10.7
Fwd PE	4.62

4.2 Price Multiples

76.32% of the companies in the same industry are more expensive than ALNXT, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	9.14
EV/EBITDA	N/A

4.3 Compensation for Growth

ALNXT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

PEG (NY)0.52

PEG (5Y)2.92

EPS Next 2Y9.47%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALNXT!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

NEXTEDIA

EPA:ALNXT (1/14/2026, 7:00:00 PM)

0.428

0 (-0.7%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustryIT Services

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners17.68%

Ins Owner ChangeN/A

Market Cap16.70M

Revenue(TTM)62.04M

Net Income(TTM)1.55M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	10.7
Fwd PE	4.62
P/S	0.27
P/FCF	9.14
P/OCF	8.73
P/B	0.53
P/tB	14.4
EV/EBITDA	N/A

EPS(TTM)0.04

EY9.35%

EPS(NY)0.09

Fwd EY21.66%

FCF(TTM)0.05

FCFY10.94%

OCF(TTM)0.05

OCFY11.45%

SpS1.59

BVpS0.81

TBVpS0.03

PEG (NY)0.52

PEG (5Y)2.92

Graham Number0.85

Profitability

		Industry Rank	Sector Rank
ROA	2.83%
ROE	4.93%
ROCE	8.85%
ROIC	6.3%
ROICexc	7.81%
ROICexgc	N/A
OM	5.15%
PM (TTM)	2.5%
GM	54.19%
FCFM	2.94%

ROA(3y)2.64%

ROA(5y)3.08%

ROE(3y)5.31%

ROE(5y)6.42%

ROIC(3y)6.2%

ROIC(5y)6.1%

ROICexc(3y)8.02%

ROICexc(5y)8.4%

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)8.71%

ROCE(5y)8.58%

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3Y-9.69%

ROICexc growth 5Y-0.48%

OM growth 3Y-10.16%

OM growth 5Y-2.26%

PM growth 3Y-8.02%

PM growth 5Y-2.63%

GM growth 3Y-8.46%

GM growth 5Y-11.02%

F-Score7

Asset Turnover1.13

Health

		Industry Rank	Sector Rank
Debt/Equity	0.12
Debt/FCF	3.1
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	0.14%
Interest Coverage	250
Cash Conversion	N/A
Profit Quality	117.82%
Current Ratio	1.25
Quick Ratio	1.25
Altman-Z	2.15

F-Score7

WACC6.83%

ROIC/WACC0.92

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)0.47%

Cap/Sales(5y)0.35%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)48.13%

EPS 3Y-3.66%

EPS 5Y3.66%

EPS Q2Q%4.76%

EPS Next Y20.64%

EPS Next 2Y9.47%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-2.25%

Revenue growth 3Y8.74%

Revenue growth 5Y21.48%

Sales Q2Q%-8.17%

Revenue Next Year13.87%

Revenue Next 2Y8.18%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y5.19%

EBIT growth 3Y-2.31%

EBIT growth 5Y18.73%

EBIT Next Year22.44%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-22.15%

FCF growth 3Y-11.08%

FCF growth 5YN/A

OCF growth 1Y-33.49%

OCF growth 3Y-10.82%

OCF growth 5YN/A

NEXTEDIA / ALNXT.PA FAQ

Can you provide the ChartMill fundamental rating for NEXTEDIA?

ChartMill assigns a fundamental rating of 5 / 10 to ALNXT.PA.

What is the valuation status of NEXTEDIA (ALNXT.PA) stock?

ChartMill assigns a valuation rating of 7 / 10 to NEXTEDIA (ALNXT.PA). This can be considered as Undervalued.

What is the profitability of ALNXT stock?

NEXTEDIA (ALNXT.PA) has a profitability rating of 3 / 10.

How financially healthy is NEXTEDIA?

The financial health rating of NEXTEDIA (ALNXT.PA) is 5 / 10.

NEXTEDIA (ALNXT.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

NEXTEDIA / ALNXT.PA FAQ

Can you provide the ChartMill fundamental rating for NEXTEDIA?

What is the valuation status of NEXTEDIA (ALNXT.PA) stock?

What is the profitability of ALNXT stock?

How financially healthy is NEXTEDIA?